Skip to content

Modern Slavery Statement

Aspen Group statement on Modern Slavery Preamble Increasingly international legislation and protocol require companies to act in respect of modern slavery. Specifically, the UK Modern Slavery Act and the Australian Modern Slavery Act require companies to disclose their efforts to address the risk of modern slavery in their businesses. This statement provides insight into Aspen’s…

Read More

Aspen concludes strategic partnership with US-based Avion Pharmaceuticals

Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius, both wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, have announced a license and commercialisation agreement with Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, for the exclusive rights to relaunch Cenestin® in the USA. This is a New Drug Application…

Read More

Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate

Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South African subsidiaries, Pharmacare Limited (which trades as “Aspen Pharmacare”), has entered into a preliminary agreement with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the technical transfer and proposed commercial…

Read More

Aspen increases revenue by 9% to R38,6 billion

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced reviewed provisional Group financial results for the year ended 30 June 2020. COMMENTARY RESHAPING OF THE GROUP The recently announced agreement to divest the assets related to the commercialisation of Aspen’s Thrombosis business in Europe to Mylan…

Read More

Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary

Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (“Mylan”) will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis…

Read More

Ethicare donates 3 000 face shields to pharmacists

An Ethicare initiative The unprecedented arrival of COVID-19 in South Africa forced everyone to come to terms with a new normal. The grave reality of the pandemic was highlighted with the announcement of a national lockdown on 23 March 2020. This drastic measure was implemented to flatten the curve and slow the spread of the…

Read More

Aspen celebrates a decade of participation in Mandela Day

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is celebrating its 10th year of participation in the annual Mandela International Day (Mandela Day) campaign. Stephen Saad, Aspen Group Chief Executive said, “We participated in our first initiative in 2011 when we partnered with the Rekopane Inclusive Development…

Read More

Aspen debuts in the FTSE4Good Index Series

The annual FTSE Russell Environmental, Social and Governance (ESG) Ratings have been published and Aspen has been included as a constituent member in the global FTSE4Good Index Series for the first time. Jeanette Englund Aspen Group Risk Sustainability Manager said, “We are delighted to be included in the global FTSE4Good Index Series for the first…

Read More

Honouring ICU Nurses as Healthcare Heroes

An Intensive Care Unit (ICU) Nurse is a highly trained specialised registered nurse who delivers vital care to seriously ill or injured patients in ICUs of hospitals and healthcare facilities. They treat patients who have suffered strokes, heart attacks, or undergone invasive surgery and, more recently their role in the treatment of COVID-19 patients has…

Read More
Scroll To Top